The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: Search for anticancer agent
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Untangling the ErbB signalling network
Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974
Pao, W., Miller, V., Zakowski, M., Doherty, J., Politi, K., Sarkaria, I., Singh, B., Heelan, R., Rusch, V., Fulton, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405220101 · Cited by 4,338
Alley, M. C., Scudiero, D. A., Monks, A. P., Hursey, M. L., Czerwiński, M., Fine, D. L., Abbott, B. J., Mayo, J. G., Shoemaker, R. H., & Boyd, M. R. (1988) · PubMed · Cited by 3,082
Boyd, M. R., & Paull, K. D. (1995) · Drug Development Research · doi:10.1002/ddr.430340203 · Cited by 1,572
A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)
Wood, E. R., Truesdale, A. T., McDonald, O. B., Yuan, D., Hassell, A., Dickerson, S. H., Ellis, B., Pennisi, C., Horne, E., Lackey, K., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1168 · Cited by 1,122
The National Cancer Institute: cancer drug discovery and development program.
Grever, M. R., Schepartz, S. A., & Chabner, B. A. (1992) · PubMed · Cited by 722
Kinetic and Catalytic Mechanisms of Protein Kinases
Adams, J. A. (2001) · Chemical Reviews · doi:10.1021/cr000230w · Cited by 627
Burris, H. A., Hurwitz, H. I., Dees, E. C., Dowlati, A., Blackwell, K. L., O'Neil, B., Marcom, P. K., Ellis, M. J., Overmoyer, B., Jones, S. F., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.16.584 · Cited by 619
Barker, A. J., Gibson, K. H., Grundy, W., Godfrey, A. A., Barlow, J. J., Healy, M. P., Woodburn, J. R., Ashton, S. E., Curry, B. J., Scarlett, L., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00344-4 · Cited by 569
Protein kinases as targets for anticancer agents: from inhibitors to useful drugs
Fabbro, D., Ruetz, S., Buchdunger, E., Cowan-Jacob, S. W., Fendrich, G., Liebetanz, J., Mestan, J., O'Reilly, T., Traxler, P., Chaudhuri, B., et al. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00179-1 · Cited by 335
Hennequin, L. F., Stokes, E. S. E., Thomas, A. P., Johnstone, C., Plé, P. A., Ogilvie, D. J., Dukes, M., Wedge, S. R., Kendrew, J., & Curwen, J. O. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm011022e · Cited by 311
Krantz, A., Spencer, R. W., Tam, T. F., Liak, T. J., Copp, L. J., Thomas, E. M., & Rafferty, S. P. (1990) · Journal of Medicinal Chemistry · doi:10.1021/jm00164a002 · Cited by 273
Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation.
Kovalenko, M. V., Gazit, A., Böhmer, A., Rorsman, C., Rönnstrand, L., Heldin, C., Waltenberger, J. L., Böhmer, F., & Levitzki, A. (1994) · PubMed · Cited by 269
Rostom, S. A. F. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.06.020 · Cited by 243
Tyrosine kinase inhibitors in cancer therapy
Madhusudan, S., & Ganesan, T. S. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.05.006 · Cited by 236
Al-Obaid, A. M., Abdel-Hamide, S. G., El-Kashef, H. A., Abdel-Aziz, A. A.-M., El-Azab, A. S., Al-Khamees, H. A., & El-Subbagh, H. I. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.09.015 · Cited by 197
Al-Rashood, S. T., Aboldahab, I. A., Nagi, M. N., Abouzeid, L. A., Abdel-Aziz, A. A. M., Abdel-hamide, S. G., Youssef, K. M., Al-Obaid, A. M., & El-Subbagh, H. I. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.08.030 · Cited by 191
Tyrosine kinase inhibitors—ZD1839 (Iressa)
Arteaga, C. L., & Johnson, D. H. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200111000-00012 · Cited by 172
Manjula, S. N., Noolvi, N. M., Vipan, K. P., Reddy, S. A. M., Ramani, V., Gadad, A. K., Singh, G., Kutty, N. G., & Rao, C. M. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.12.002 · Cited by 148
Abdel‐Aziz, A. A. ‐. (2006) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2006.12.003 · Cited by 141
Al-Omary, F. A. M., Abou-zeid, L. A., Nagi, M. N., Habib, E. E., Abdel‐Aziz, A. A. ‐., El‐Azab, A. S., Abdel‐Hamide, S. G., Al-Omar, M. A., Al-Obaid, A. M., & El‐Subbagh, H. I. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.03.019 · Cited by 132
Epidermal growth factor receptor tyrosine kinase inhibitors
Ranson, M. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601873 · Cited by 118
Novel halogenated sulfonamides inhibit the growth of multidrug resistant MCF-7/ADR cancer cells
Medina, J. C., Roche, D., Shan, B., Learned, R. M., Frankmoelle, W. P., Clark, D. L., Rosen, T., & Jaén, J. C. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00276-0 · Cited by 86
Antonello, A., Tarozzi, A., Morroni, F., Cavalli, A., Rosini, M., Hrelia, P., Bolognesi, M. L., & Melchiorre, C. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0608762 · Cited by 85
Klutchko, S. R., Zhou, H., Winters, R. T., Tran, T. P., Bridges, A. J., Althaus, I. W., Amato, D. M., Elliott, W. L., Ellis, P. A., Meade, M. A., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050936o · Cited by 81
Synthesis and SAR of potent EGFR/erbB2 dual inhibitors
Zhang, Y., Cockerill, S. G., Guntrip, S. B., Rusnak, D. W., Smith, K., Vanderwall, D. E., Wood, E. R., & Lackey, K. E. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.10.010 · Cited by 51
Barlési, F., Tchouhadjian, C., Doddoli, C., Villani, P., Greillier, L., Kleisbauer, J. P., Thomas, P. A., & Astoul, P. J. (2005) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2005.00323.x · Cited by 50
Lapatinib: A Sword With Two Edges
Kopper, L. (2008) · Pathology & Oncology Research · doi:10.1007/s12253-008-9018-z · Cited by 50
Pannala, M., Kher, S. M., Wilson, N., Gaudette, J., Sircar, I., Zhang, S., Bakhirev, A., Yang, G. Z., Yuen, P., Gorcsan, F., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.07.071 · Cited by 44
Dhillon, S., & Wagstaff, A. J. (2007) · Drugs · doi:10.2165/00003495-200767140-00008 · Cited by 39
EGFR-targeting agents in oncology
Garofalo, S., Rosa, R., Bianco, R., & Tortora, G. (2008) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.18.8.889 · Cited by 30
Cited by
Cu and Cu-Based Nanoparticles: Synthesis and Applications in Catalysis
Gawande, M. B., Goswami, A., Felpin, F.-X., Asefa, T., Huang, X., Silva, R., Zou, X., Zboril, R., & Varma, R. S. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00482 · Cited by 2,934
Khandelwal, S., Tailor, Y. K., & Kumar, M. (2016) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2015.12.015 · Cited by 572
Metadata
- Authors
- Noolvi, M. N., Patel, H. M., Bhardwaj, V., & Chauhan, A.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 46
- Issue
- 6
- Pages
- 2327-2346
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W2150031760
- Cited by
- 283
- References
- 33
- FWCI
- 7.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.